Read + Share
Amedeo Smart
Independent Medical Education
Georgiou M, Ntavelou P, Stokes W, Roy R, et al. Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma. Oncogene 2022 May 30. pii: 10.1038/s41388-022-02354.PMID: 35637251
Email
LinkedIn
Facebook
Twitter
Privacy Policy